Rome-IV functional gastrointestinal disorders (FGIDs)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria (all must be met simultaneously): 1. Age 8-12 years old, gender not restricted; 2. Meet the diagnostic criteria for functional gastrointestinal disorders in children according to the Rome IV criteria: 1) Functional abdominal pain disorder: Abdominal pain does not meet the diagnostic criteria for other functional gastrointestinal disorders; the pain is not related to eating or defecation; the symptoms persist for at least 2 months, with at least 4 occurrences per month; 2) Irritable bowel syndrome: At least 4 days of abdominal pain per month; accompanied by at least two of the following: related to defecation, change in defecation frequency, change in stool consistency; the symptoms persist for at least 2 months, with at least 4 occurrences per month; 3) Functional dyspepsia: Post-meal fullness, early satiety, upper abdominal pain or burning sensation, at least 4 days per month; the symptoms are not related to defecation; the symptoms persist for at least 2 months; 4) Abdominal migraine: At least 2 occurrences in the past 6 months; episodic, severe periumbilical or midline abdominal pain, lasting for 1 hour or more; no symptoms between attacks; often accompanied by nausea, vomiting, photophobia, etc. 3. Guardians and children give informed consent and voluntarily participate in this study; 4. Have basic reading and writing skills in Chinese and can cooperate to complete scale assessment and intervention training. Whether you can participate in the study requires final decision by a doctor after examination.
Exclusion criteria
Exclusion criteria: Exclusion criteria (any one of the following conditions will disqualify one from participating): 1. Having severe organic diseases (such as inflammatory bowel disease, metabolic diseases, neurological disorders, etc.); 2. Having a clear diagnosis of mental disorder at present or in the past (such as depression, anxiety disorder, autism spectrum disorder, etc.); 3. Having received systematic psychological treatment or participated in other intervention-based clinical studies in the recent 3 months; 4. The researcher deems that there are any other circumstances that make one ineligible to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Salivary cortisol level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions related to mindfulness practice;Diary of Abdominal Pain Symptoms;Serious Adverse Event (SAE);SCARED Anxiety Scale Score;Vital signs;Children's Blood Pressure Scale Score;DSRSC Depression Scale Score;Adverse event;Intestinal microbiota alpha diversity; | — |
Countries
China
Contacts
Beijing Childrens Hospital,Capital Medical University